CPCB-RPE1

· Regenerative Patch Technologies, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CPCB-RPE1, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) [Phase 2]

See pricing